|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| High-risk women hesitant to take breast cancer preventive drug. |
|
|
Dec 3, 2009 |
459 |
| United States : Genetic Variation Of Enzyme Linked With Outcomes For Women Receiving Tamoxifen. |
|
|
Nov 2, 2009 |
446 |
| MRTF-A transactivates COMT gene and decreases the anti-tumor effects of tamoxifen. |
Liu, Zhi-Peng; Luo, Xue-Gang; Guo, Shu; Wang, Jian-Xin; Zhang, Xin; Wang, Nan; Jiang, Yong; Zhang, T |
Report |
Nov 1, 2009 |
2602 |
| United States : Enzyme Variation Influences Effectiveness of Breast Cancer Treatment. |
|
|
Oct 12, 2009 |
415 |
| Survival Benefit Maintained in Long Term Follow-up of IES with Pfizer's AROMASIN[R] (Exemestane Tablets). |
|
|
Sep 22, 2009 |
1062 |
| 3 drugs found to reduce breast cancer risk, have distinct side effects. |
|
|
Sep 16, 2009 |
422 |
| Resistance to hormone therapy in breast cancer. |
Hiscox, Stephen; Nicholson, Robert I. |
Report |
Sep 1, 2009 |
4410 |
| Long-term tamoxifen use may up aggressive breast cancer risk. |
|
|
Aug 26, 2009 |
299 |
| Breast cancer drug effective against life-threatening fungal infections too. |
|
|
Jul 21, 2009 |
423 |
| The clinical importance of patient adherence to therapy. |
Fallowfield, Lesley |
Report |
Jun 1, 2009 |
2006 |
| For those on tamoxifen, an antidepressant alarm. |
|
|
May 31, 2009 |
751 |
| Cholesterol 'increases breast cancer drug's resistance'. |
|
|
Apr 21, 2009 |
414 |
| Nuvera Biosciences Licenses Therapy-Directed Diagnostic Tests in Breast Cancer to Veridex, LLC. |
|
|
Apr 6, 2009 |
787 |
| Tamoxifen-induced pseudo-menopausal syndrome symptoms. |
Flaws, Bob |
Clinical report |
Jan 1, 2009 |
1313 |
| Breast cancer drug that cuts the risk of dying by a fifth. |
|
|
Dec 12, 2008 |
482 |
| Drug could cause cancer to spread; Shock new figures reveal patients in Valleys waiting longer for ambulances than anywhere else in Wales. |
|
|
Dec 4, 2008 |
354 |
| Popular breast cancer drug 'could make disease more aggressive'. |
|
|
Dec 4, 2008 |
338 |
| Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen. |
|
|
Dec 1, 2008 |
1216 |
| New insight into drug resistance; In association with the NHS. |
|
|
Nov 17, 2008 |
234 |
| Genetic clue could lead to better breast cancer drugs; The drug fails in a third of cases. |
|
|
Nov 13, 2008 |
427 |
| Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration of CTP-347 and Tamoxifen. |
|
|
Sep 25, 2008 |
637 |
| Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. |
Murray, Nick |
Report |
Sep 1, 2008 |
429 |
| Compugen Planning Proof of Concept Human Trial for Breast Cancer Drug Candidate in 2009. |
|
|
Jul 16, 2008 |
868 |
| Tamoxifen may improve mania in bipolar disorder. |
Moon, Mary Ann |
|
Jun 1, 2008 |
252 |
| Side Effects with Aromatase Inhibitors. |
|
|
Jun 1, 2008 |
752 |
| HABITS Redux. |
|
|
Jun 1, 2008 |
1295 |
| Study looks at cancer recurrence; Breast tumors; Potential treatment could reduce risk for survivors. |
|
Report |
Mar 11, 2008 |
330 |
| Pharmacology Watch: Another Study Implicates Avandia. |
|
Medical condition overview |
Feb 1, 2008 |
1284 |
| Long-term Results with Tamoxifen in Prevention of Breast Cancer. |
|
|
Dec 1, 2007 |
936 |
| Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics. |
|
|
Oct 22, 2007 |
1122 |
| Side effects force women off cancer pills. |
|
|
Sep 10, 2007 |
485 |
| Tamoxifen reduces mania in bipolar patients. |
Tucker, Miriam E. |
|
Jul 1, 2007 |
361 |
| Mechanisms of endocrine resistance. |
Leary, Alexandra; Johnston, Stephen |
|
Jun 1, 2007 |
6275 |
| Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. |
Wardley, Andrew |
|
Jun 1, 2007 |
577 |
| Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer. |
Murray, Nick |
|
Jun 1, 2007 |
544 |
| Cost-utility of adjuvant hormone therapies with aromatase inhibitors in postmenopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and tamoxifen-letrozole. |
Murray, Nick |
|
Jun 1, 2007 |
573 |
| Tamoxifen shown to reduce risk of ER-positive breast cancer. |
McBride, Deborah |
|
Jun 1, 2007 |
441 |
| Breast cancer drug bonus. |
|
|
Feb 21, 2007 |
325 |
| [pounds sterling]30 drug that can cut risk of breast cancer. |
|
|
Feb 21, 2007 |
559 |
| Lives can be saved with new oestrogen-lowering drug; The World Today. |
|
|
Feb 13, 2007 |
209 |
| Breast cancer drug could save 1,300 lives a year. |
|
|
Feb 13, 2007 |
181 |
| Tamoxifen benefit lasts 10 years, new data show: the relative risk of breast cancer was reduced by a highly significant 29%, compared with placebo. |
Jancin, Bruce |
|
Feb 1, 2007 |
784 |
| Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor [beta]. |
Vijayanathan, Veena; Greenfield, Norma J.; Thomas, T.J.; Ivanova, Margarita M.; Tyulmenkov, Valentyn |
Clinical report |
Feb 1, 2007 |
9295 |
| Small study: tamoxifen may lift mania in bipolar. |
MacNeil, Jane Salodof |
|
Nov 1, 2006 |
562 |
| United States Court of Appeals denies rehearing request in dismissal of Tamoxifen Citrate antitrust lawsuits. |
|
|
Sep 1, 2006 |
449 |
| Study sees limit in tamoxifen as a life saver. |
|
|
Jul 24, 2006 |
691 |
| Results of Raloxifene RUTH and STAR Trials. |
|
|
Jun 1, 2006 |
1508 |
| Two drugs are equal in preventing breast cancer. |
|
Brief article |
May 6, 2006 |
211 |
| Cytogen and Savient Sign Letter of Intent for Marketing Of SOLTAMOX(TM); The First Oral Liquid Tamoxifen in the U.S. Represents a New Option for Women with Breast Cancer Including Patients Unable to Tolerate Solid Oral Dosage Forms. |
|
|
Feb 8, 2006 |
1758 |
| Pharmacology Watch: Letrozole for Postmenopausal Women with Breast Cancer. |
|
|
Feb 1, 2006 |
1266 |
| Breast cancer drug'better than Tamoxifen'. |
|
|
Dec 29, 2005 |
224 |
| Drug OK'd to prevent tumor's return; Breast cancer; Study: Femara beats tamoxifen. |
|
|
Dec 29, 2005 |
390 |
| Protective progeny: peptide treats and prevents breast cancer. |
Greene, Katie |
|
Nov 12, 2005 |
504 |
| Cure-all drug remains risky. |
|
Brief Article |
Feb 1, 2005 |
313 |
| Effects of estradiol 17-beta and tamoxifen on MCF-7 human breast cancer cells. |
Jenkins, Latoya; Raychoudhury, Samir |
|
Jan 1, 2005 |
204 |
| Exemestane after tamoxifen therapy in breast cancer. |
Kuritzky, Louis |
Brief Article |
May 1, 2004 |
249 |
| Raloxifene appears to hold benefits for older women: patients randomized to the drug demonstrated a significantly decreased probability of impairment on tests of verbal recall. |
Splete, Heidi |
|
May 1, 2004 |
853 |
| Tamoxifen in the prevention of breast cancer. |
|
Brief Article |
May 1, 2004 |
239 |
| Comparing apples to apples, oranges to oranges: learning the difference between relative and absolute risk. |
Cassels, Alan |
|
Mar 1, 2004 |
846 |
| Prevention of breast cancer with tamoxifen. |
|
Author Abstract |
Oct 1, 2003 |
440 |
| Prevention of Breast Cancer with Tamoxifen. |
|
|
Oct 1, 2003 |
392 |
| Selective estrogen receptor modulators. (Featured CME Topic). |
Haskell, Sally G. |
|
May 1, 2003 |
6839 |
| Drug treatments to prevent breast cancer. |
|
|
Apr 1, 2003 |
835 |
| Drug Treatments to Prevent Breast Cancer. |
|
|
Apr 1, 2003 |
799 |
| Tamoxifen update. (Nutrition Detective). |
|
Brief Article |
Mar 1, 2003 |
229 |
| Effects of polychlorinated biphenyl Aroclor 1242 on MCF-7 cells. (South Carolina Academy of Sciences Abstracts). |
Mackal-Moore, Shannel; Oliver, Rush |
Brief Article |
Jan 1, 2003 |
137 |
| First results from the international breast cancer intervention study (IBIS-I): a randomized prevention trial. |
|
|
Nov 1, 2002 |
1316 |
| First Results from the International Breast Cancer Intervention Study (IBIS-I): A Randomized. |
|
Clinical report |
Nov 1, 2002 |
1338 |
| Tamoxifen and breast cancer. (The Nutrition Detective). |
Williams, Rose Marie |
Brief Article |
Aug 1, 2002 |
135 |
| Tamoxifen and Breast Cancer incidence among women with inherited mutations in BRCA1 and BRCA2. |
|
|
Jan 1, 2002 |
930 |
| Tamoxifen and Breast Cancer Incidence Among Women with Inherited Mutations in BRCA1 and BRCA2. |
|
|
Jan 1, 2002 |
946 |
| CME Questions. |
|
|
Jan 1, 2002 |
224 |
| Drugs tested for Lou Gehrig's disease. (Biomedicine). |
|
Brief Article |
Dec 8, 2001 |
346 |
| The Small Blue Cell Dilemma Associated With Tamoxifen Therapy. |
Yang, Yi Jun; Trapkin, Linda K.; Demoski, Roberta K.; Bellerdine, Jeannette; Powers, Celeste N. |
Statistical Data Included |
Aug 1, 2001 |
3040 |
| Tamoxifen dilates arteries in men. |
|
Brief Article |
May 5, 2001 |
269 |
| Is Tamoxifen Safe and Effective? |
Fuchs, Nan Kathryn |
Product/Service Evaluation |
Apr 1, 2001 |
1204 |
| Do Anti-estrogens Protect Against Breast Cancer? |
Fuchs, Nan Kathryn |
Brief Article |
Jan 1, 2001 |
222 |
| Screening for Endometrial Disease in Tamoxifen Users. |
|
Clinical report |
Jan 1, 2001 |
1002 |
| Update on Tamoxifen- Associated Endometrial Cancer in Breast Cancer Patients. |
|
|
Jan 1, 2000 |
1057 |
| Update on Tamoxifen-Associated Endometrial Cancer in Breast Cancer Patients. |
Gershenson, David M. |
|
Jan 1, 2000 |
1036 |
| Designer Estrogens. |
CHRISTENSEN, DAMARIS |
|
Oct 16, 1999 |
2599 |
| Therapy for Intraductal Carcinoma of the Breast. |
|
|
Aug 1, 1999 |
652 |
| Therapy for Intraductal Carcinoma of the Breast. |
|
|
Aug 1, 1999 |
725 |
| Study Tries Breast Cancer Drug Tamoxifen for Abortion Yet Another Chemical Abortifacient? |
O'Bannon, Randall K. |
|
Mar 15, 1999 |
1815 |
| Tamoxifen and Ocular Toxicity. |
|
|
Mar 1, 1999 |
579 |
| Tamoxifen Cuts the Risk of Breast Cancer in Half. |
|
Clinical report |
Dec 1, 1998 |
1190 |
| Tamoxifen clears hurdle to preventive use. |
Raloff, Janet |
|
Sep 12, 1998 |
690 |
| European Tamoxifen Prevention Studies Do Not Agree With American Results. |
|
|
Sep 1, 1998 |
576 |
| Tamoxifen may not prevent breast cancer. |
Brainard, Jeffrey |
Brief Article |
Jul 18, 1998 |
610 |
| Great news in the battle against breast cancer. |
Gramling, Jack |
Product/Service Evaluation |
May 1, 1998 |
359 |
| Drug prevents some cancer, poses risks. |
Raloff, Janet |
Brief Article |
Apr 11, 1998 |
410 |
| Magnetic fields can diminish drug action. |
Raloff, Janet |
Brief Article |
Nov 29, 1997 |
671 |
| Tamoxifen's other anticancer hat. |
Raloff, Janet |
Brief Article |
Apr 5, 1997 |
220 |
| Tamoxifen Therapy Should Last 5 Years. |
|
|
Mar 22, 1997 |
150 |
| Tamoxifen therapy should last 5 years. |
|
Brief Article |
Nov 23, 1996 |
324 |
| U.N. body rules tamoxifen a carcinogen. |
Raloff, Janet |
Brief Article |
Mar 2, 1996 |
365 |
| Tamoxifen use limited. |
Seachrist, Lisa |
Brief Article |
Dec 9, 1995 |
299 |
| State asks: is tamoxifen a carcinogen? |
|
|
Oct 7, 1995 |
592 |
| Tamoxifen derivative shrinks mouse tumors. |
Lipkin, Richard |
Brief Article |
Apr 15, 1995 |
416 |
| Study reaffirms tamoxifen's dark side. |
Adler, Tina |
|
Jun 4, 1994 |
442 |
|
